---

Liver Abscess

---

1. Classification & Etiology

---

2. Pyogenic Liver Abscess (PLA)

Routes of Infection

1. Biliary tract disease (most common, ~35%) - cholangitis, cholecystitis, biliary obstruction from stones or malignancy, post-biliary surgery/endoscopy
2. Portal vein pyemia (~20%) - ascending infection from appendicitis, diverticulitis, IBD, perforated peptic ulcer, peritonitis
3. Trauma - blunt or penetrating hepatic injury
4. Hematogenous - via hepatic artery from systemic bacteremia (e.g., endocarditis)
5. Cryptogenic (~40%) - no identifiable source; frequently associated with Klebsiella pneumoniae and occult colonic malignancy

Cryptogenic PLA and colon cancer: Multiple studies have linked cryptogenic PLA to underlying colonic malignancy, and some guidelines recommend colonoscopy after diagnosis of cryptogenic PLA to rule out occult cancer. - Current Surgical Therapy 14e

Risk Factors

• Age
• Diabetes mellitus (increases recurrence risk 12-38%)
• Biliary malignancy or instrumentation
• Immunosuppression
• Liver transplant
• Proton pump inhibitor use (independent risk factor - may allow gut bacterial overgrowth)
• Cirrhosis

Microbiology

• Biliary-origin PLAs: E. coli, Klebsiella, Enterococcus
• Enteric-origin PLAs: Bacteroides and anaerobes
• Cryptogenic PLAs: often monomicrobial K. pneumoniae (virulent strains can cause metastatic infection - endophthalmitis, meningitis)
• Fungal abscesses (Candida): hematologic malignancy patients

---

3. Clinical Features

---

4. Diagnosis

Imaging

Laboratory

• Blood cultures (positive in >50% of PLA cases)
• Aspiration cultures (90% yield if pre-antibiotic)
• CBC: leukocytosis, anemia
• LFTs: elevated ALP, bilirubin, transaminases
• Elevated ESR

Differential Diagnosis

---

5. Treatment

A. Pyogenic Liver Abscess

Antibiotics

• Piperacillin/tazobactam (monotherapy) - standard first-line
• Ceftriaxone + metronidazole - alternative
• Carbapenems - if history of biliary instrumentation/transplant (ESBL coverage)

Drainage - Standard of Care

• Higher treatment success (RR 1.19, 95% CI 1.10-1.29, p<0.001)
• Faster clinical improvement (1.92 days shorter, p<0.001)
• Lower 6-month recurrence (RR 0.44, 95% CI 0.26-0.75, p<0.001)
• With comparable complication rates

Surgery

Recurrent/Refractory Abscesses

---

6. Amebic Liver Abscess (ALA)

Epidemiology & Pathophysiology

• Caused by Entamoeba histolytica (protozoan)
• 10:1 male-to-female predominance
• Usually single abscess in the right hepatic lobe, near the diaphragm
• Cysts ingested via fecally contaminated food/water → colitis → trophozoites invade intestinal mucosa → portal seeding → hepatic abscess, typically 2-4 months after colonic amebiasis
• Classic abscess contents: thick, proteinaceous, brown "anchovy paste" fluid

Diagnosis

• Travel history to endemic areas (Mexico, India, Africa, Southeast Asia)
• Amebic serology (ELISA, indirect hemagglutination) - highly sensitive
• Antigen testing more specific than antibody serology (1/3 of prior E. histolytica infection patients retain antibodies without active infection)
• Stool O&P: positive in only ~50%

Comparison Table: PLA vs ALA

Treatment of ALA

1. Oral metronidazole 500-750 mg TID x 7-10 days - highly effective (>90% response)
2. PLUS luminal agent to eliminate intestinal cysts and prevent recurrence:
   • Paromomycin 10 mg/kg TID x 7 days, OR
   • Diiodohydroxyquin (iodoquinol) 650 mg TID x 20 days

• No clinical response to antibiotics
• Suspicion of secondary bacterial superinfection (broaden antibiotics + drain)

Important contrast: Drainage is standard of care for PLA but not indicated for uncomplicated ALA. - Current Surgical Therapy 14e

---

7. Fungal Hepatic Abscess

• Almost exclusively in immunocompromised patients, particularly those with hematologic malignancies (leukemia, lymphoma)
• Highest mortality among all types
• Caused mainly by Candida species
• Treated with systemic antifungals (amphotericin B or azoles based on species)

---

8. Complications

• Rupture into peritoneum (peritonitis), pleural cavity (empyema, fistula), or pericardium (tamponade)
• Right pleural effusion / subphrenic abscess
• Portal vein thrombosis / portal hypertension
• Septicemia, multi-organ failure
• Metastatic infection (with virulent K. pneumoniae strains: endophthalmitis, meningitis)

---

9. Prognosis

---

• Sleisenger and Fordtran's Gastrointestinal and Liver Disease, Ch. 84
• Bailey and Love's Short Practice of Surgery, 28th Ed., Ch. 69
• Current Surgical Therapy, 14th Ed.
• Li & Pan, Medicine 2025 - Meta-analysis: PCD vs PA for liver abscess (PMID 40958348)

---

Minimally Invasive Treatment Modalities for Hydatid Cysts of the Liver

Overview and General Principles

1. Eradication of the parasite within the cyst
2. Protection of the host against spillage of scoleces (using scolicidal agents)
3. Management of residual cavity and complications

---

Role of Medical Therapy (Anthelmintic - Adjunct to All Approaches)

• Used alone, benzimidazoles achieve only ~30% success rate
• Given for at least 3 months preoperatively, albendazole reduces cyst viability, recurrence risk, and the consequences of inadvertent spillage
• If spillage occurs intraoperatively, therapy should continue for at least 1 month postoperatively
• Praziquantel may be added preoperatively to further reduce scolex viability

---

1. PAIR (Puncture - Aspiration - Injection - Re-Aspiration)

Steps of the PAIR Technique

1. Puncture: The cyst wall is punctured under ultrasound or CT guidance using a fine needle (typically 18-22 gauge)
2. Aspiration: Cyst fluid is aspirated completely - fluid is characteristically clear and colorless ("hydatid water"). Suction must be capable of high negative pressures
3. Injection: A protoscolecidal (scolicidal) agent is instilled into the cyst cavity and left for 15-30 minutes. Contrast may be injected first to opacify the cyst and rule out biliary communication
4. Re-aspiration: The scolicidal solution and residual contents are completely re-aspirated

Scolicidal Agents Used in PAIR

Important safety rule: No agent should be injected pre-evacuation due to high intracyst pressure - injection before aspiration risks rupture and systemic spread. - Maingot's

• Relatively low risk: ethanol (70-95%), hypertonic saline (15-20%), cetrimide 0.5%
• Formalin and hydrogen peroxide have been abandoned due to toxic biliary effects

Patient Selection for PAIR (WHO-PAIR criteria)

• Gharbi type I or II cysts (unilocular, non-complicated)
• Anterior and peripheral cysts
• 1-3 cysts
• Small-to-moderate size
• No calcification or minimal calcification
• No biliary communication (must be confirmed prior to scolicidal injection)

Results

• Two small randomized trials compared PAIR with surgery and with medical therapy, showing similar success rates, though both had methodologic limitations
• PAIR is now accepted in centers experienced with the technique and is endorsed by WHO as an alternative to surgery in selected patients
• Sabiston Textbook of Surgery

---

2. Percutaneous Catheter Drainage (Modified PAIR / MoCAS)

• Prolonged evacuation of cyst contents
• Repeated irrigations with scolicidal agents
• Management of infected cysts
• Drainage of biliary communication (if identified post-procedure)

• Larger cysts
• Infected cysts (functioning like a pyogenic abscess drain)
• When daughter cysts or debris preclude complete single-session aspiration

Both PAIR and percutaneous drainage are contraindicated when biliary or pulmonary communication is demonstrated - scolicidal agents injected into the biliary tree cause sclerosing cholangitis. - Maingot's

---

3. Laparoscopic Cyst Surgery

Patient Selection

• Anteriorly placed, superficial cysts
• Cysts without thick calcified walls
• Segments VI-VII cysts (via right lateral approach)
• Gharbi type I or II cysts
• Not suitable for: posterior/central cysts, multiple (>3) cysts, heavily calcified cysts, biliary communication requiring formal repair

Technique: Laparoscopic Marsupialization (Deroofing)

1. An 11 mm trocar is placed just above the cyst
2. Scolicidal agent (10% povidone-iodine-soaked sponges, or hypertonic saline) is applied around the cyst field
3. The cyst is aspirated with a 14-gauge needle (the endocyst shrinks back from the pericyst wall)
4. The pericyst is opened (deroofed), and daughter cysts and germinal membrane are evacuated using suction and graspers
5. The cyst cavity is irrigated with scolicidal solution
6. Any biliary communication is identified and oversewn
7. A pedicled omentum flap (omentoplasty) is sutured to the margins of the residual cavity to obliterate it, reduce bile leak, and prevent fluid collection

Technique: Laparoscopic Cystopericystectomy

Advantages of Laparoscopy over Open Surgery

• Reduced hospital stay
• Less postoperative pain
• Faster recovery
• Lower wound complications
• Similar efficacy for suitable cysts

Spillage Prevention (Critical)

• Trocar sites and peritoneal cavity are lined with hypertonic saline-soaked packs before cyst opening
• Closed aspiration systems are used to prevent aerosol contamination
• Preoperative albendazole (+ praziquantel) reduces scolex viability
• Intraoperative spillage of cyst contents is the primary cause of recurrence (8.5-25% postoperative recurrence rate in conservative surgery) - Maingot's

---

4. Endoscopic Retrograde Cholangiopancreatography (ERCP)

• Biliary communication occurs in up to 80% of cases as cysts enlarge (through compression-related decubitus erosion of bile ducts) - Maingot's
• Clinical manifestations: jaundice, cholangitis, cyst infection, external biliary fistula post-surgery
• ERCP with sphincterotomy decompresses the biliary tree and can extract extruded membranes or daughter cysts that have entered the common bile duct
• Biliary stenting via ERCP can also manage postoperative biliary fistulae (12-33% of patients with biliary communication require biliary drainage postoperatively)
• ERCP is preferred over surgical bile duct exploration in many centers when the communication is not amenable to simple suture repair

---

5. Summary: Selection Framework

---

Recurrence Rates

• Intraoperative spillage of protoscolex-rich fluid
• Incomplete removal of the germinal membrane
• Continued biliary communication

---

• Maingot's Abdominal Operations - Ch. 43
• Sabiston Textbook of Surgery, 21e - Ch. 89
• Bailey & Love's Short Practice of Surgery, 28th Ed. - Ch. 69
• Schwartz's Principles of Surgery, 11th Ed. - Ch. 31

---

Minimally Invasive Treatment Modalities for Hydatid Cysts of the Liver

Overview and General Principles

1. Eradication of the parasite within the cyst
2. Protection of the host against spillage of scoleces (using scolicidal agents)
3. Management of residual cavity and complications

---

Role of Medical Therapy (Albendazole - Adjunct to All Approaches)

• Alone, benzimidazoles achieve only ~30% success
• Given for at least 3 months preoperatively, albendazole reduces cyst viability and recurrence risk after spillage
• Praziquantel may be added preoperatively to further reduce scolex viability
• Post-procedure albendazole continues for at least 1 month if spillage occurs

---

1. PAIR (Puncture - Aspiration - Injection - Re-Aspiration)

Steps of PAIR

1. Puncture - the cyst wall is punctured under ultrasound or CT guidance (fine needle, 18-22 gauge)
2. Aspiration - all cyst contents are aspirated; fluid is typically clear ("hydatid water"). Contrast may be injected first to confirm no biliary communication
3. Injection - a scolicidal agent is instilled and left for 15-30 minutes
4. Re-aspiration - scolicidal solution and residual contents are fully re-aspirated

Critical rule: No scolicidal agent should be injected before aspiration because high intracyst pressure risks rupture and systemic seeding. - Maingot's

Scolicidal Agents

Patient Selection for PAIR

---

2. Percutaneous Catheter Drainage (Modified PAIR / MoCAS)

• Prolonged and repeated drainage of cyst contents
• Serial irrigation with scolicidal agents over days
• Management of infected/superinfected cysts (functioning like a pyogenic abscess drain)
• Evacuation of viscous daughter cyst material that cannot be aspirated in a single session

---

3. Laparoscopic Cyst Surgery

Best Suited For

• Anteriorly placed, superficial cysts
• Cysts without thick calcified walls
• Gharbi type I or II
• Segments VI-VII cysts (via right lateral port approach)
• 1-3 cysts

Not Suitable For

• Posterior/central/deeply embedded cysts

• 3 cysts or very large cysts

• Heavily calcified pericysts
• Confirmed biliary communication requiring formal biliary reconstruction

---

Technique A: Laparoscopic Marsupialization (Deroofing)

1. An 11 mm port is placed just above the cyst
2. Povidone-iodine-soaked sponges or hypertonic saline packs are placed around the field as a scolicidal barrier
3. The cyst is aspirated with a 14-gauge needle (the endocyst shrinks away from the pericyst wall)
4. The pericyst roof is resected (deroofed); daughter cysts and germinal membrane are evacuated with suction/graspers
5. The cavity is irrigated with scolicidal solution
6. Any biliary communication is identified and oversewn
7. A pedicled omentum flap (omentoplasty) is sutured to the cyst margins to obliterate the dead space, reduce bile leak risk, and prevent fluid collection

Technique B: Laparoscopic Cystopericystectomy

Spillage Prevention (Critical)

• Peritoneal cavity and port sites lined with hypertonic saline-soaked packs before cyst opening
• Closed suction systems used throughout
• Preoperative albendazole (+/- praziquantel) reduces scolex viability before any manipulation
• Intraoperative spillage of protoscolex-rich fluid is the primary driver of recurrence (8.5-25% in conservative surgery) - Maingot's

---

4. ERCP (Endoscopic Retrograde Cholangiopancreatography)

• Biliary communication occurs in up to 80% of cases as enlarging cysts erode adjacent bile ducts
• Clinical presentations: jaundice, cholangitis, cyst superinfection, obstructive jaundice, external biliary fistula after surgery
• ERCP with sphincterotomy decompresses the biliary tree and allows extraction of membranes or daughter cysts that have migrated into the common bile duct
• Endoscopic biliary stenting manages postoperative biliary fistulae (12-33% of patients with biliary communication require postoperative biliary drainage) - Maingot's
• ERCP is preferred over open bile duct exploration for post-procedural biliary leak in many centers

---

5. Selection Framework Summary

---

Recurrence Rates Across Approaches

---

• Maingot's Abdominal Operations - Ch. 43
• Sabiston Textbook of Surgery, 21e - Ch. 89
• Bailey & Love's Short Practice of Surgery, 28th Ed. - Ch. 69
• Schwartz's Principles of Surgery, 11th Ed. - Ch. 31

Hepatic Hydatid Cyst: Etiopathogenesis, Classification, Investigations, and Management

---

Part 1 - Etiopathogenesis

The Parasite

• E. granulosus - most common; causes cystic echinococcosis; endemic in the Mediterranean, Middle East, South America, Australia, New Zealand, and Africa
• E. multilocularis - less common; causes alveolar echinococcosis; behaves like a malignant infiltrating tumor; 5-year mortality of ~70% and 10-year mortality ~94% untreated; endemic in central Europe, Russia, Turkey, China, Japan

Life Cycle and Transmission

1. Ingestion of ova from environment contaminated by dog feces (via contaminated food, water, vegetables, or direct contact with infected dogs)
2. In the human duodenum, the protective chitinous layer is dissolved by gastric juice
3. The released hexacanth embryo (oncosphere) burrows through the intestinal wall
4. It enters the portal circulation (or lymphatics) and is transported to the liver - the first-pass filter and most frequently involved organ
5. Those passing through the liver are trapped in the pulmonary capillary bed; the few escaping to systemic circulation may seed the brain, bones, or spleen

Cyst Growth and Structure

• 1 cm in the first 6 months
• 2-3 cm annually thereafter
• They are frequently very large at presentation (often >10 cm) because growth is slow and initially asymptomatic

• Hydatid fluid: clear, colorless, antigenic; contains salts, enzymes, proteins, and toxic substances; under high pressure
• Brood capsules: small cellular masses budding from the germinal layer, each containing future worm heads (protoscoleces)
• Protoscoleces: each has 4 suckers and a double row of hooks; ~400,000 per mL of fluid; can differentiate into adult tapeworms in a definitive host or into new daughter cysts in an intermediate host
• Hydatid sand: the combination of freed brood capsules + protoscoleces + calcareous bodies (appears as echogenic foci on ultrasound)
• Daughter cysts: formed when the endocyst proliferates; replicas of the mother cyst; develop after >6 months of cyst growth

• Endogenic (normal): daughter cysts form within the mother cyst
• Ectogenic: the germinal layer protrudes through a small defect in the laminated membrane to form a satellite cyst - characteristic of E. multilocularis, leading to fulminant multilocular infiltration, necrosis, and hepatic insufficiency - Maingot's

Complications of Untreated Cysts

1. Rupture into the biliary tree - most common complication (biliary communication occurs in up to 80% of cases from progressive pressure erosion); presents as cholangitis, obstructive jaundice, or biliary colic with passage of membrane fragments
2. Secondary infection/superinfection - cyst becomes a pyogenic abscess
3. Rupture into the peritoneum - can cause acute abdomen, anaphylactic shock, and catastrophic seeding ("white cancer") - very difficult to treat
4. Rupture into the pleural/pulmonary cavity - bronchopleural fistula; "hydatid vomica" (expectoration of salty cyst fluid + white membranes)
5. Anaphylaxis - from leak or rupture of cyst antigens into the bloodstream
6. Compression of adjacent structures - portal hypertension, IVC obstruction, biliary obstruction
7. Cyst calcification and death - benign outcome; but calcification does not guarantee death of the parasite

---

Part 2 - Classification

WHO-IWGE Classification (2003, Updated) - Gold Standard

• Group 1 (Active): CE1, CE2 - cysts >2 cm, often fertile
• Group 2 (Transitional): CE3 - degenerating but may still harbor viable protoscolices
• Group 3 (Inactive): CE4, CE5 - degenerated, partially or totally calcified; unlikely to contain viable protoscolices

Important: Calcification does not always confirm a dead cyst. If an inactive cyst is enlarging on serial imaging, it should be treated. - Bailey & Love's

---

Part 3 - Investigations

A. Clinical Assessment

• History of exposure: sheep-farming, dog contact, endemic area travel
• 75% of patients are asymptomatic at diagnosis
• When symptomatic: RUQ/epigastric pain (20%), dyspepsia (13%), fever/chills (8%), jaundice (6%)
• Signs: RUQ mass (70%), RUQ tenderness (20%)

B. Laboratory Tests

C. Serology (Immunodiagnostics)

Serology may be negative if: the cyst has never leaked, contains no scolices (sterile cyst), or the parasite is no longer viable (calcified, dead cyst). - Schwartz's

D. Imaging

Chest X-Ray

• May show elevated right hemidiaphragm
• Concentric calcifications in cyst wall
• Limited diagnostic value alone

Ultrasound (First-Line Investigation)

• Preferred initial modality - widely available, inexpensive, radiation-free, and can be performed bedside
• Specificity ~90% for hydatid disease
• Defines: internal structure, number and location of cysts, presence of daughter cysts, biliary communication, and complications
• Can detect cysts as small as 1 cm
• Pathognomonic signs: hydatid sand (mobile echogenic foci = "snowflake sign"), floating membrane (water-lily sign), daughter cysts with rosette/honeycomb appearance

CT Scan

• Most accurate for surgical planning
• Clearly defines: cyst location relative to bile ducts and vascular structures, extent of calcification, biliary communication, and extrahepatic disease
• Ring-like pericyst calcifications present in 20-30% on CT
• Dense total calcification suggests a dead/inactive cyst
• Daughter cysts appear slightly hypodense compared to the mother cyst

MRI

• Best modality for evaluating pericyst characteristics, cyst matrix, and daughter cyst composition
• Useful when CT is equivocal or for central cysts near portal structures
• MRCP can demonstrate biliary communication even before clinical jaundice

ERCP / MRCP

• Indicated when biliary communication is suspected preoperatively (jaundice, cholangitis, elevated ALP)
• Cholangiography or ERCP should be performed before any percutaneous drainage to rule out biliary communication (injection of scolicidal agent into a communicating biliary tree causes sclerosing cholangitis)

Aspiration without preparation is contraindicated - risk of anaphylaxis and peritoneal seeding. - Rosen's Emergency Medicine

---

Part 4 - Management

Overview: Decision Framework

• Cyst type (WHO-IWGE classification)
• Size, number, and location of cysts
• Presence of complications (biliary communication, rupture, infection)
• Patient factors (fitness for surgery, comorbidities, pregnancy, age)
• Available expertise and infrastructure

Treatment Options Summary

---

A. Medical Therapy (Anthelmintic)

• Dose: 400 mg orally twice daily (in patients ≥60 kg); or 10-15 mg/kg/day divided BD (in patients <60 kg); max 800 mg/day
• Mechanism: absorbed from the GI tract, metabolized by the liver to its active sulfoxide form; concentrates well in cyst fluid
• Mebendazole is inferior: poorly absorbed and inactivated by the liver
• Success rate as monotherapy: ~30% (cyst disappearance in <50% of patients)
• Praziquantel (25 mg/kg/day orally) combined with albendazole is superior to albendazole alone

1. Adjunct to all interventions - given preoperatively (minimum 1 day, ideally ≥3 months) and postoperatively (minimum 1 month if viable scolices present)
2. Reduces cyst viability and risk of recurrence after intraoperative spillage
3. Alone: only for widely disseminated disease or patients unfit for any intervention; NOT indicated for inactive/calcified cysts (except in complicated disease)

---

B. PAIR (Puncture - Aspiration - Injection - Re-aspiration)

1. Albendazole started preoperatively
2. Under ultrasound or CT guidance, the cyst is punctured with a fine needle
3. Cyst contents are aspirated (clear "hydatid water")
4. Contrast is injected to confirm no biliary communication (mandatory before scolicidal instillation)
5. Scolicidal agent is instilled and left for 10-30 minutes
6. Complete re-aspiration of scolicidal agent and residual contents
7. Final irrigation with 0.9% saline

• CE1 and CE3 cysts >5 cm
• CE2 cysts (multivesicular - may need catheter drainage variant)
• Infected cysts
• Patients refusing or unfit for surgery
• Failure of medical therapy alone
• Post-surgical recurrence

• Biliary communication (confirmed or suspected)
• Pulmonary communication
• Peritoneal rupture
• CE4 or CE5 (inactive/calcified) cysts
• Inaccessible or superficial cysts at risk of peritoneal leak
• Children <3 years

---

C. Percutaneous Catheter Drainage (Modified PAIR)

• Giant unilocular cysts (>10 cm)
• Infected cysts (acts like a pyogenic abscess drain)
• CE3B or CE2 cysts with thick, viscous contents requiring multiple sessions

---

D. Laparoscopic Surgery

Indications

• CE1, CE2, CE3 cysts: anterior, peripheral, non-calcified
• Cysts in segments VI-VII (right lateral approach)
• 1-3 cysts
• No biliary communication

Not Suitable For

• Posterior/central/deeply buried cysts

• 3 cysts

• Heavy calcification (thick pericyst)
• Biliary communication requiring formal biliary reconstruction

Laparoscopic Marsupialization (Deroofing)

1. Hypertonic saline-soaked packs placed around the cyst field
2. Cyst aspirated with 14-gauge needle (endocyst shrinks away from pericyst)
3. Roof of pericyst excised; daughter cysts and germinal membrane evacuated
4. Cavity irrigated with scolicidal agent
5. Any biliary communication oversewn
6. Omentoplasty - pedicled omentum sutured into the residual cavity to obliterate dead space and reduce bile leak

Laparoscopic Cystopericystectomy (Total Pericystectomy)

• The entire cyst is excised intact without entering it
• Ideal for small, superficial cysts in expert centers
• Lowest recurrence rate among minimally invasive approaches
• Requires advanced laparoscopic hepatobiliary skills

---

E. Open Surgery

Indications for Open Surgery

• Large CE2-CE3 cysts with multiple daughter cysts
• Cysts at risk of spontaneous rupture (superficial)
• Biliary communication (especially when percutaneous options not available)
• Peritoneal rupture
• Pulmonary/bronchial communication
• Failure of percutaneous approaches
• Mass effect on adjacent vital structures
• Central/posterior/deeply located cysts

Conservative (Partial) Approaches

• Field packed with 20% hypertonic saline-soaked gauze
• Cyst aspirated via closed high-suction system
• Cyst opened completely; debris meticulously cleared
• Cavity irrigated with scolicidal agent
• Biliary openings identified and oversewn
• Residual cavity managed by omentoplasty
• Recurrence: 10-30%

• The remaining pericyst walls are sutured together (invaginated) to obliterate the residual cavity
• Used when omentoplasty is not feasible

Radical Approaches (Lower Recurrence, Higher Morbidity)

• Entire cyst, including the pericyst, is removed intact
• Requires precise knowledge of bile duct and vascular anatomy
• Recurrence: ~10%
• Major morbidity (bile leak, bleeding): ~20%

• For centrally located cysts or those involving major vascular/biliary structures
• Ensures complete removal with lowest recurrence
• Most suitable for large CE2-CE3 cysts, failed pericystectomy, or E. multilocularis
• Morbidity ~40%; formal planning with intraoperative ultrasound essential
• Recurrence: ~10%

• Reserved for end-stage E. multilocularis with extensive hepatic destruction
• Rare indication

Principles of Intraoperative Spillage Prevention

1. Peritoneal cavity lined with hypertonic saline-soaked packs before cyst opening
2. Closed suction aspiration system used
3. Scolicidal agent injected after evacuation (never before - high intracyst pressure risks rupture)
4. If spillage occurs: peritoneal washout with hypertonic saline + albendazole 3-6 months + praziquantel 7 days
5. Scolicidal injection contraindicated if biliary communication is present (sclerosing cholangitis)

---

F. Management of Specific Complications

---

Summary Decision Algorithm

Hepatic Hydatid Cyst
        │
        ├── Inactive (CE4/CE5) + asymptomatic → Watch and wait
        │
        ├── Small (<4 cm), deep, uncomplicated → Albendazole alone
        │
        ├── CE1 or CE3 (>5 cm), no biliary comms → PAIR + albendazole
        │
        ├── CE2 / giant cysts / infected → Catheter drainage + albendazole
        │
        ├── Anterior/peripheral, 1-3 cysts, no biliary comms → Laparoscopic surgery
        │
        ├── Biliary communication / posterior / multiple / large → Open surgery
        │
        └── Failed all above / E. multilocularis → Hepatic resection ± transplantation

---

• Maingot's Abdominal Operations - Ch. 43
• Current Surgical Therapy, 14th Ed. - (Hydatid Disease section)
• Sabiston Textbook of Surgery, 21e - Ch. 89
• Bailey & Love's Short Practice of Surgery, 28th Ed. - Ch. 6 & Ch. 69
• Rosen's Emergency Medicine - Ch. 122
• Schwartz's Principles of Surgery, 11th Ed. - Ch. 31